NCI website aids cancer trial recruitment

An online tool lets cancer researchers collaborate and commiserate on subject recruitment. Much of the accumulated knowledge on cancer trial recruitment is scattered among those who have conducted the trials. Some appears in literature.

AccrualNet, developed by the National Cancer Institute and unveiled at the recent Cancer Trial Accrual Symposium, functions as an aggregator of this knowledge and makes it accessible to the cancer research community. The goals of the site are to increase knowledge about the processes needed for success in clinical trial accrual, and to encourage use of available resources. The site and the project that led to it are described in a recent NCI Cancer Bulletin special issue devoted to trials enrollment.

The developers have created a community of practice, to which visitors contribute materials, tips, experience, and practices. An annotated list of journal articles on trial recruitment and links to relevant publications are included, as well as tools to aid recruitment efforts.

- see the article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.